Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06358651
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-04-04
Brief Title:
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder PALISADE-3
Sponsor:
VistaGen Therapeutics Inc
Organization:
VistaGen Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Social Anxiety Disorder |
Keywords:
| Name | View |
|---|---|
| Fasedienol | View |
| PH94B | View |
| Social Anxiety Disorder | View |
| SAD | View |
| pherine | View |
| pherine nasal spray | View |
| acute treatment | View |
| anxiety treatment | View |
| acute anxiety treatment | View |
| anxiotlytic | View |
| mental health | View |
| anxiety | View |
| anxiety nasal spray | View |
| PSC | View |
| public speaking challenge | View |
| social phobia | View |